Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the postCOVID-19 era: results of a prospective, multicenter study in Argentina Navegación de entradas Activity in vitro of new beta-lactam beta-lactamase inhibitor combinations against Burkholderia cepacia Complex (Bcc) and Burkholderia gladioli (Bgl) isolated from patients with cystic fibrosis Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology?